CARIS LIFE SCIENCES, INC. Investing Cash Flow
CARIS LIFE SCIENCES, INC. (CAI) reported Investing Cash Flow of -$132.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$122.19M.
- CARIS LIFE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$10.34M.
- CARIS LIFE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$5.09M.
- CARIS LIFE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$7.09M.
- CARIS LIFE SCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$16.26M, a 130.72% decline from fiscal 2024.
- CARIS LIFE SCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2024 was $52.93M, a 75.35% decline from fiscal 2023.
- CARIS LIFE SCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2023 was $214.77M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$122.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$132.53M 10-Q · filed 2026-08-05 | -$137.62M derived: sum of 3 quarters · filed 2026-08-05 | -$144.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$10.34M 10-Q · filed 2026-05-08 | -$15.43M derived: sum of 2 quarters · filed 2026-05-08 | -$22.53M derived: sum of 3 quarters · filed 2026-05-08 | -$23.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$12.19M derived: sum of 2 quarters · filed 2026-03-03 | -$13.57M derived: sum of 3 quarters · filed 2026-08-05 | -$16.26M 10-K · filed 2026-03-03 |
| 2025-09-30 | -$7.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$8.48M derived: sum of 2 quarters · filed 2026-08-05 | -$11.17M 10-Q · filed 2025-11-05 | -$13.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.08M 10-Q · filed 2026-08-05 | -$6.37M derived: sum of 3 quarters · filed 2026-08-05 | -$8.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$2.69M 10-Q · filed 2026-05-08 | -$4.98M derived: sum of 2 quarters · filed 2026-05-08 | -$6.81M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$4.12M derived: sum of 2 quarters · filed 2026-03-03 | $52.93M 10-K · filed 2026-03-03 | |
| 2024-09-30 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $55.22M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $57.05M 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $214.77M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |